EZH2 and osteosarcoma: For example, miR-101 decreases the invasion and migration ability of several tumor types, including osteosarcoma in vitro and gastric cancer and glioblastoma in vitro and in vivo, through the post-transcriptional downregulation of EZH2 [37–39].